skip to the main content

Boditech Med obtains an export license and CE cert. for Boditech Quick™ COVID-19 Ag test kit

We are pleased to share the news that Boditech Quick™ COVID-19 Ag obtained an export license from the Ministry of Food and Drug Safety of Korea, in addition to completing the CE certification process. As of the second quarter, the company will begin exporting the product to key regions including Europe, Asia, and Latin America.

Boditech Quick COVID-19 Ag became the first COVID-19 Ag test kit for saliva sample to be permitted for export in Korea. It is also the first COVID-19 diagnostic product developed by Boditech Med whose results come out within 30 minutes and can be read with the eye.

The product’s level of accuracy examined through clinical studies is 80% sensitivity and 100% specificity. Moreover, the product has the advantage of being consistent in sensitivity, while existing COVID-19 Ag diagnostic kits can generate significant variations in sensitivity depending on the sampling methods.

A company official said, “thanks to the merit of not requiring any analyzers and the convenience of sample collection, the new product is garnering considerable interest in key markets. We are discussing OEM manufacturing opportunities with European companies, and it is also being watched with keen interest from Asian and South American markets. We expect that Boditech Quick COVID-19 Ag, along with the other COVID-19 antigen test kits, will drive growth in the second half of this year.”